Vox Sanguinis International Forum on typing and matching strategies in patients on anti‐CD38 monoclonal therapy: summary
暂无分享,去创建一个
V. Deneys | A. Buser | A. Greinacher | M. Murphy | J. Staves | N. Marwaha | E. Zhiburt | K. D. de Vooght | P. Perseghin | L. Infanti | A. Holbro | M. Dassi | J. Storry | J. Pendergrast | H. Hustinx | R. Sharma | C. Cserti-Gazdewich | D. Brilhante | C. Thiry | A. Frélik | J. Kutner | K. Selleng | M. Lundgren | J. Bueno | M. Lozano | L. Castilho | M. Colling | A. Incontri | A. Jain | A. Macedo | J. Hawes | I. Romera | C. Bonet Bub | R. Kaufman | A. Alarcón | K. Suzuki
[1] G. Clarke,et al. Transfusion management of patients receiving daratumumab therapy for advanced plasma cell myeloma , 2015, Transfusion.
[2] N. Blumberg,et al. An alternative method to dithiothreitol treatment for antibody screening in patients receiving daratumumab , 2015, Transfusion.
[3] J. Laubach,et al. Resolving the daratumumab interference with blood compatibility testing , 2015, Transfusion.
[4] P. Parren,et al. When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy , 2015, Transfusion.
[5] Thomas E. Pampush,et al. An Alternative Method , 1984, Fascism.